首页 > 最新文献

Obstetrical & Gynecological Survey最新文献

英文 中文
Cannabis and Pregnancy: A Review. 大麻与怀孕:综述。
IF 4.3 4区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2023-07-01 DOI: 10.1097/OGX.0000000000001159
Sarena Hayer, Ava D Mandelbaum, Lester Watch, Kimberly S Ryan, Madeline A Hedges, Jennifer A Manuzak, Charles A Easley, Danny J Schust, Jamie O Lo

Importance: Prenatal cannabis use is rising and is a major public health issue. Cannabis use in pregnancy and during lactation has been associated with increased maternal and offspring morbidity and mortality.

Objective: This review aims to summarize the existing literature and current recommendations for cannabis use during pregnancy or lactation.

Evidence acquisition: A PubMed, Cochrane Library, and Google Scholar literature search using the following terms was performed to gather relevant data: "cannabis," "cannabinoid," "delta-9-tetrahydrocannabinol," "THC," "cannabidiol," "fetal outcomes," "perinatal outcomes," "pregnancy," and "lactation."

Results: Available studies on cannabis use in pregnancy and during lactation were reviewed and support an association with increased risk of preterm birth, neonatal intensive care unit admission, low birth weight, and small-for-gestational-age infants.

Conclusion and relevance: There is a critical need for research on the effects of cannabis use in pregnancy and during lactation. This is a necessary first step before furthering patient education, developing interventions, and targeting antenatal surveillance to ameliorate the adverse impacts on maternal and fetal health.

重要性:产前使用大麻的人数不断增加,这是一个重大的公共卫生问题。孕期和哺乳期吸食大麻与母婴发病率和死亡率增加有关:本综述旨在总结现有文献以及关于孕期或哺乳期使用大麻的现行建议:使用以下术语对 PubMed、Cochrane 图书馆和 Google Scholar 进行文献检索,以收集相关数据:"大麻"、"大麻素"、"δ-9-四氢大麻酚"、"四氢大麻酚"、"大麻二酚"、"胎儿结局"、"围产期结局"、"妊娠 "和 "哺乳期":对有关孕期和哺乳期吸食大麻的现有研究进行了回顾,结果表明,吸食大麻与早产、入住新生儿重症监护室、低出生体重和小于胎龄婴儿的风险增加有关:亟需对孕期和哺乳期吸食大麻的影响进行研究。这是进一步开展患者教育、制定干预措施和有针对性地进行产前监测以减轻对孕产妇和胎儿健康的不利影响之前必须迈出的第一步。
{"title":"Cannabis and Pregnancy: A Review.","authors":"Sarena Hayer, Ava D Mandelbaum, Lester Watch, Kimberly S Ryan, Madeline A Hedges, Jennifer A Manuzak, Charles A Easley, Danny J Schust, Jamie O Lo","doi":"10.1097/OGX.0000000000001159","DOIUrl":"10.1097/OGX.0000000000001159","url":null,"abstract":"<p><strong>Importance: </strong>Prenatal cannabis use is rising and is a major public health issue. Cannabis use in pregnancy and during lactation has been associated with increased maternal and offspring morbidity and mortality.</p><p><strong>Objective: </strong>This review aims to summarize the existing literature and current recommendations for cannabis use during pregnancy or lactation.</p><p><strong>Evidence acquisition: </strong>A PubMed, Cochrane Library, and Google Scholar literature search using the following terms was performed to gather relevant data: \"cannabis,\" \"cannabinoid,\" \"delta-9-tetrahydrocannabinol,\" \"THC,\" \"cannabidiol,\" \"fetal outcomes,\" \"perinatal outcomes,\" \"pregnancy,\" and \"lactation.\"</p><p><strong>Results: </strong>Available studies on cannabis use in pregnancy and during lactation were reviewed and support an association with increased risk of preterm birth, neonatal intensive care unit admission, low birth weight, and small-for-gestational-age infants.</p><p><strong>Conclusion and relevance: </strong>There is a critical need for research on the effects of cannabis use in pregnancy and during lactation. This is a necessary first step before furthering patient education, developing interventions, and targeting antenatal surveillance to ameliorate the adverse impacts on maternal and fetal health.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372687/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9886210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibiotic Recommendations After Postpartum Uterine Exploration or Instrumentation. 产后子宫探查或仪器检查后的抗生素建议。
IF 6.2 4区 医学 Q2 Medicine Pub Date : 2023-07-01 DOI: 10.1097/OGX.0000000000001167
Katherine A Lambert, Anne West Honart, Brenna L Hughes, Jeffrey A Kuller, Sarah K Dotters-Katz

Importance: Multiple postpartum scenarios require uterine exploration or instrumentation. These may introduce bacteria into the uterus, increasing the risk of endometritis. Data on the use of antibiotics in these scenarios is limited, resulting in few guidelines and divergent care.

Objective: To describe postpartum scenarios requiring uterine exploration and/or instrumentation, review data on antibiotic prophylaxis, and delineate antibiotic recommendations for each scenario.

Evidence acquisition: Original articles were obtained from literature search in PubMed, MEDLINE, and OVID; pertinent articles were reviewed.

Results: These recommendations are based on published evidence and professional society guidelines. Antibiotic prophylaxis following manual placenta removal should include 1-time combination of ampicillin 2 g intravenously (IV) or cefazolin 1 g IV, plus metronidazole 500 mg IV. Antibiotic prophylaxis before postpartum dilation and curettage, manual vacuum aspiration, and intrauterine balloon tamponade should include 1-time combination of ampicillin 2 g IV plus metronidazole 500 mg IV. If the patient in any of the above scenarios has received group B Streptococcus prophylaxis, then only metronidazole is recommended. Further randomized clinical trials are needed to optimize these regimens.

Conclusions: Uterine exploration or instrumentation increases the risk of postpartum endometritis and requires antibiotic prophylaxis. For manual placenta removal, we recommend 1-time combination of ampicillin 2 g IV or cefazolin 1 g IV, plus metronidazole 500 mg IV. For dilation and curettage, manual vacuum aspiration, and intrauterine balloon tamponade, we recommend 1-time combination of ampicillin 2 g IV plus metronidazole 500 mg IV. For patients who already received antibiotic prophylaxis for group B Streptococcus, we recommend 1-time dose of metronidazole 500 mg IV.

Relevance: Providers can utilize our guidelines to prevent postpartum endometritis in these scenarios requiring postpartum uterine exploration and/or instrumentation.

重要性:多种产后情况需要子宫探查或器械。这些可能会将细菌引入子宫,增加子宫内膜炎的风险。在这些情况下使用抗生素的数据有限,导致指南很少,护理也不一致。目的:描述需要子宫探查和/或器械的产后情况,回顾抗生素预防的数据,并描述每种情况的抗生素建议。证据获取:原始文章来源于PubMed、MEDLINE和OVID的文献检索;对相关文章进行了综述。结果:这些建议是基于已公布的证据和专业协会的指导方针。手动胎盘摘除后的抗生素预防应包括1次注射2 g氨苄青霉素静脉注射(IV)或1 g头孢唑林静脉注射加甲硝唑500 mg IV。产后扩张和刮宫、手动真空抽吸和宫内球囊填塞前的抗生素预防应该包括1次加用2 g氨苄西林静脉注射加500 mg甲硝唑IV。如果患者在上述任何一种情况下接受了B组链球菌预防治疗,则建议仅使用甲硝唑。需要进一步的随机临床试验来优化这些方案。结论:子宫探查或子宫内固定会增加产后子宫内膜炎的风险,需要预防抗生素。对于手动胎盘切除,我们建议1次联合使用氨苄青霉素2 g IV或头孢唑林1 g IV,再加上甲硝唑500 mg IV。对于扩张和刮宫、手动真空抽吸和宫内球囊填塞,我们建议一次联合使用青霉素2 g IV+甲硝唑500 mg IV.对于已经接受B组链球菌抗生素预防的患者,我们建议1次剂量的甲硝唑500 mg IV。相关性:在需要产后子宫探查和/或器械的情况下,提供者可以利用我们的指南来预防产后子宫内膜炎。
{"title":"Antibiotic Recommendations After Postpartum Uterine Exploration or Instrumentation.","authors":"Katherine A Lambert,&nbsp;Anne West Honart,&nbsp;Brenna L Hughes,&nbsp;Jeffrey A Kuller,&nbsp;Sarah K Dotters-Katz","doi":"10.1097/OGX.0000000000001167","DOIUrl":"10.1097/OGX.0000000000001167","url":null,"abstract":"<p><strong>Importance: </strong>Multiple postpartum scenarios require uterine exploration or instrumentation. These may introduce bacteria into the uterus, increasing the risk of endometritis. Data on the use of antibiotics in these scenarios is limited, resulting in few guidelines and divergent care.</p><p><strong>Objective: </strong>To describe postpartum scenarios requiring uterine exploration and/or instrumentation, review data on antibiotic prophylaxis, and delineate antibiotic recommendations for each scenario.</p><p><strong>Evidence acquisition: </strong>Original articles were obtained from literature search in PubMed, MEDLINE, and OVID; pertinent articles were reviewed.</p><p><strong>Results: </strong>These recommendations are based on published evidence and professional society guidelines. Antibiotic prophylaxis following manual placenta removal should include 1-time combination of ampicillin 2 g intravenously (IV) or cefazolin 1 g IV, plus metronidazole 500 mg IV. Antibiotic prophylaxis before postpartum dilation and curettage, manual vacuum aspiration, and intrauterine balloon tamponade should include 1-time combination of ampicillin 2 g IV plus metronidazole 500 mg IV. If the patient in any of the above scenarios has received group B <i>Streptococcus</i> prophylaxis, then only metronidazole is recommended. Further randomized clinical trials are needed to optimize these regimens.</p><p><strong>Conclusions: </strong>Uterine exploration or instrumentation increases the risk of postpartum endometritis and requires antibiotic prophylaxis. For manual placenta removal, we recommend 1-time combination of ampicillin 2 g IV or cefazolin 1 g IV, plus metronidazole 500 mg IV. For dilation and curettage, manual vacuum aspiration, and intrauterine balloon tamponade, we recommend 1-time combination of ampicillin 2 g IV plus metronidazole 500 mg IV. For patients who already received antibiotic prophylaxis for group B <i>Streptococcus</i>, we recommend 1-time dose of metronidazole 500 mg IV.</p><p><strong>Relevance: </strong>Providers can utilize our guidelines to prevent postpartum endometritis in these scenarios requiring postpartum uterine exploration and/or instrumentation.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":null,"pages":null},"PeriodicalIF":6.2,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9906923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Simulation Training on the Management of Shoulder Dystocia and Incidence of Permanent Brachial Plexus Birth Injury: An Observational Study 模拟训练对肩部难产处理及永久性臂丛分娩损伤发生率的影响:一项观察性研究
4区 医学 Q2 Medicine Pub Date : 2023-07-01 DOI: 10.1097/ogx.0000000000001174
Marja Kaijomaa, Mika Gissler, Outi Äyräs, Assi Sten, Petra Grahn
(Abstracted from BJOG 2023;130:70–77) The incidence of brachial plexus birth injury (BPBI) varies from 0.4 to 3.8 per 1000 vaginal births. It is a complication caused by traction to the cervical and thoracic nerve roots that can lead to decreased strength, complete paralysis, or limited range of motion in the affected limb in the first year of life.
(abstract from BJOG 2023; 130:70-77)阴道分娩时臂丛分娩损伤(brachial plexus birth injury, BPBI)的发生率为0.4 - 3.8 / 1000。这是一种由牵引颈、胸神经根引起的并发症,可导致一岁发病肢体力量下降、完全瘫痪或活动范围受限。
{"title":"Impact of Simulation Training on the Management of Shoulder Dystocia and Incidence of Permanent Brachial Plexus Birth Injury: An Observational Study","authors":"Marja Kaijomaa, Mika Gissler, Outi Äyräs, Assi Sten, Petra Grahn","doi":"10.1097/ogx.0000000000001174","DOIUrl":"https://doi.org/10.1097/ogx.0000000000001174","url":null,"abstract":"(Abstracted from BJOG 2023;130:70–77) The incidence of brachial plexus birth injury (BPBI) varies from 0.4 to 3.8 per 1000 vaginal births. It is a complication caused by traction to the cervical and thoracic nerve roots that can lead to decreased strength, complete paralysis, or limited range of motion in the affected limb in the first year of life.","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135509337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Double-blinded, Randomized Trial Comparing Surgeon-Administered Transversus Abdominis Plane Block With Placebo After Midline Laparotomy in Gynecologic Oncology Surgery 一项双盲随机试验,比较妇科肿瘤手术中线剖腹手术后外科给药的经腹平面阻滞与安慰剂
4区 医学 Q2 Medicine Pub Date : 2023-07-01 DOI: 10.1097/01.ogx.0000947148.64785.3a
Laurence Bernard, Melissa Lavecchia, Gabrielle Trepanier, Sarah Mah, Alida Pokoradi, Justin M. McGinnis, Mohammad Alyafi, Bryan Glezerson, Julie Nguyen, Vanessa Carlson, Limor Helpman, Laurie Elit, Waldo Jimenez, Lua Eiriksson, Clare J. Reade
(Abstracted from Am J Obstet Gynecol 2023;228:553.e1–553.e8) The transversus abdominis plane (TAP) block is an anesthetic technique wherein a local anesthetic solution is into the fascial plane between the transversus abdominis and the internal oblique muscles. The TAP block has been shown to reduce requirements of opioids after surgery; however, it can be time-consuming for use in the operating room setting.
(摘要:《中华妇产科杂志》2023;228:553.e1-553.e8)腹横面阻滞(TAP)是一种局部麻醉溶液进入腹横肌与内斜肌之间的筋膜平面的麻醉技术。TAP阻滞已被证明可以减少手术后对阿片类药物的需求;然而,在手术室中使用它可能很耗时。
{"title":"A Double-blinded, Randomized Trial Comparing Surgeon-Administered Transversus Abdominis Plane Block With Placebo After Midline Laparotomy in Gynecologic Oncology Surgery","authors":"Laurence Bernard, Melissa Lavecchia, Gabrielle Trepanier, Sarah Mah, Alida Pokoradi, Justin M. McGinnis, Mohammad Alyafi, Bryan Glezerson, Julie Nguyen, Vanessa Carlson, Limor Helpman, Laurie Elit, Waldo Jimenez, Lua Eiriksson, Clare J. Reade","doi":"10.1097/01.ogx.0000947148.64785.3a","DOIUrl":"https://doi.org/10.1097/01.ogx.0000947148.64785.3a","url":null,"abstract":"(Abstracted from Am J Obstet Gynecol 2023;228:553.e1–553.e8) The transversus abdominis plane (TAP) block is an anesthetic technique wherein a local anesthetic solution is into the fascial plane between the transversus abdominis and the internal oblique muscles. The TAP block has been shown to reduce requirements of opioids after surgery; however, it can be time-consuming for use in the operating room setting.","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135509339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term Childhood Outcomes for Babies Born at Term Who Were Exposed to Antenatal Corticosteroids 产前暴露于皮质类固醇的足月出生婴儿的长期儿童结局
4区 医学 Q2 Medicine Pub Date : 2023-07-01 DOI: 10.1097/01.ogx.0000947120.64129.9e
Samantha J. Osteen, Ziyi Yang, Alexandra H. McKinzie, Evgenia Teal, Robert S. Tepper, Eli Rhoads, Sara K. Quinney, Laura S. Haneline, David M. Haas
(Abstracted from Am J Obstet Gynecol 2023;228(1):80.e1–80.e6) The use of antenatal corticosteroids (ACSs) is standard practice for women who are at risk of preterm birth to accelerate the development of vital organs, in particular the fetal lungs. Previous research has shown the efficacy of this treatment and its benefits in infants who are born preterm, but there is little research on the effects of ACS on infants who are subsequently born at term.
(摘要:《中华妇产科杂志》,2023;228(1):80.e1-80.e6)产前使用皮质类固醇(ACSs)是有早产风险的妇女加速重要器官特别是胎儿肺发育的标准做法。先前的研究已经证明了这种治疗方法对早产婴儿的疗效和益处,但很少有研究表明ACS对随后足月出生的婴儿的影响。
{"title":"Long-term Childhood Outcomes for Babies Born at Term Who Were Exposed to Antenatal Corticosteroids","authors":"Samantha J. Osteen, Ziyi Yang, Alexandra H. McKinzie, Evgenia Teal, Robert S. Tepper, Eli Rhoads, Sara K. Quinney, Laura S. Haneline, David M. Haas","doi":"10.1097/01.ogx.0000947120.64129.9e","DOIUrl":"https://doi.org/10.1097/01.ogx.0000947120.64129.9e","url":null,"abstract":"(Abstracted from Am J Obstet Gynecol 2023;228(1):80.e1–80.e6) The use of antenatal corticosteroids (ACSs) is standard practice for women who are at risk of preterm birth to accelerate the development of vital organs, in particular the fetal lungs. Previous research has shown the efficacy of this treatment and its benefits in infants who are born preterm, but there is little research on the effects of ACS on infants who are subsequently born at term.","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135509346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pembrolizumab Plus Chemotherapy in Advanced Endometrial Cancer 派姆单抗联合化疗治疗晚期子宫内膜癌
4区 医学 Q2 Medicine Pub Date : 2023-07-01 DOI: 10.1097/01.ogx.0000947152.26004.f9
Ramez N. Eskander, Michael W. Sill, Lindsey Beffa, Richard G. Moore, Joanie M. Hope, Fernanda B. Musa, Robert Mannel, Mark S. Shahin, Guilherme H. Cantuaria, Eugenia Girda, Cara Mathews, Juraj Kavecansky, Charles A. Leath, Lilian T. Gien, Emily M. Hinchcliff, Shashikant B. Lele, Lisa M. Landrum, Floor Backes, Roisin E. O'Cearbhaill, Tareq Al Baghdadi, Emily K. Hill, Premal H. Thaker, Veena S. John, Stephen Welch, Amanda N. Fader, Matthew A. Powell, Carol Aghajanian
(Abstracted from N Engl J Med 2023;388(23):2159–2170) Endometrial cancer is one of the only cancer types for which both incidence and mortality are rising, and survival has not improved during the past 4 decades. First-line treatment for advanced or recurrent endometrial cancer typically involves paclitaxel plus carboplatin.
(摘要/ abstract)子宫内膜癌是近40年来发病率和死亡率均在上升的癌症类型之一,其生存率并没有提高。晚期或复发子宫内膜癌的一线治疗通常包括紫杉醇加卡铂。
{"title":"Pembrolizumab Plus Chemotherapy in Advanced Endometrial Cancer","authors":"Ramez N. Eskander, Michael W. Sill, Lindsey Beffa, Richard G. Moore, Joanie M. Hope, Fernanda B. Musa, Robert Mannel, Mark S. Shahin, Guilherme H. Cantuaria, Eugenia Girda, Cara Mathews, Juraj Kavecansky, Charles A. Leath, Lilian T. Gien, Emily M. Hinchcliff, Shashikant B. Lele, Lisa M. Landrum, Floor Backes, Roisin E. O'Cearbhaill, Tareq Al Baghdadi, Emily K. Hill, Premal H. Thaker, Veena S. John, Stephen Welch, Amanda N. Fader, Matthew A. Powell, Carol Aghajanian","doi":"10.1097/01.ogx.0000947152.26004.f9","DOIUrl":"https://doi.org/10.1097/01.ogx.0000947152.26004.f9","url":null,"abstract":"(Abstracted from N Engl J Med 2023;388(23):2159–2170) Endometrial cancer is one of the only cancer types for which both incidence and mortality are rising, and survival has not improved during the past 4 decades. First-line treatment for advanced or recurrent endometrial cancer typically involves paclitaxel plus carboplatin.","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136184753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Diagnosis and Management of Prediabetes: A Review 前驱糖尿病的诊断和治疗:综述
4区 医学 Q2 Medicine Pub Date : 2023-07-01 DOI: 10.1097/ogx.0000000000001177
Justin B. Echouffo-Tcheugui, Leigh Perreault, Linong Ji, Sam Dagogo-Jack
(Abstracted from JAMA 2023;329(14):1206–1216) Prediabetes is a highly prevalent intermediate stage of glucose dysregulation that may precede type 2 diabetes. In the United States, approximately 10% of those with prediabetes will develop diabetes each year, and the prevalence of prediabetes is steadily increasing.
(摘自《美国医学会杂志》2023;329(14):1206-1216)前驱糖尿病是一种非常普遍的血糖失调的中间阶段,可能先于2型糖尿病。在美国,每年大约有10%的前驱糖尿病患者会发展为糖尿病,而且前驱糖尿病的患病率正在稳步上升。
{"title":"Diagnosis and Management of Prediabetes: A Review","authors":"Justin B. Echouffo-Tcheugui, Leigh Perreault, Linong Ji, Sam Dagogo-Jack","doi":"10.1097/ogx.0000000000001177","DOIUrl":"https://doi.org/10.1097/ogx.0000000000001177","url":null,"abstract":"(Abstracted from JAMA 2023;329(14):1206–1216) Prediabetes is a highly prevalent intermediate stage of glucose dysregulation that may precede type 2 diabetes. In the United States, approximately 10% of those with prediabetes will develop diabetes each year, and the prevalence of prediabetes is steadily increasing.","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135509341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peripartum Pubic Symphysis Diastasis. 围产期耻骨联合分离。
IF 6.2 4区 医学 Q2 Medicine Pub Date : 2023-06-01 DOI: 10.1097/OGX.0000000000001156
Mary Katherine Anastasio, Albert T Anastasio, Jeffrey A Kuller

Importance: Peripartum separation of the pubic symphysis is a rare but potentially severe complication of childbirth, which may lead to prolonged immobilization. Thus, prompt diagnosis and treatment are paramount.

Objective: The purpose of this review is to define peripartum separation of the pubic symphysis and provide a thorough review of its etiology, clinical manifestations, diagnostic imaging techniques, management, and prognosis.

Evidence acquisition: This was a literature review using PubMed and Google Scholar.

Results: Peripartum pubic symphysis separation is defined as disruption of the pubic symphysis joint and ligamentous structures with greater than 1 cm of separation during delivery. Risk factors include fetal macrosomia, nulliparity, and precipitous labor. Patients often present with a sensation of something "giving way" in the pubic symphysis area at the time of delivery, or with severe pain in the pubic symphysis region with attempted mobilization postpartum. In severe cases, associated hematomas, pelvic fractures, sacroiliac joint disruption, and urinary tract injury may be seen. Imaging such as x-ray or ultrasound may be used to confirm the diagnosis. Although most patients recover well with conservative management, orthopedic surgical intervention may be indicated in more severe or unresolved cases.

Conclusions and relevance: Pubic symphysis separation is increasingly identified peripartum due enhanced accessibility and utilization of imaging modalities. It can be debilitating and lead to prolonged immobility postpartum. Therefore, early recognition and diagnosis are important, as this can guide decision-making for management. A multidisciplinary team approach, including coordination with obstetrics, orthopedic surgery, physical therapy, and occupational therapy should be used for early detection and treatment to ensure optimal patient outcomes.

重要性:围生期耻骨联合分离是一种罕见但潜在严重的分娩并发症,可能导致长时间的固定。因此,及时诊断和治疗是至关重要的。目的:本综述的目的是定义围生期耻骨联合分离,并提供其病因,临床表现,诊断成像技术,管理和预后的全面审查。证据获取:这是一篇使用PubMed和Google Scholar的文献综述。结果:围生期耻骨联合分离定义为分娩时耻骨联合关节和韧带结构分离大于1cm。危险因素包括巨大胎儿、无产和临产。患者通常在分娩时出现耻骨联合区“让位”的感觉,或产后试图活动时耻骨联合区剧烈疼痛。严重者可出现血肿、骨盆骨折、骶髂关节断裂和尿路损伤。影像学如x光或超声可用于确认诊断。虽然大多数患者在保守治疗下恢复良好,但在更严重或未解决的病例中可能需要骨科手术干预。结论和意义:耻骨联合分离越来越多地被识别围产期由于提高了可及性和利用成像方式。它会使人衰弱,并导致产后长时间不活动。因此,早期识别和诊断非常重要,因为这可以指导管理决策。多学科团队的方法,包括产科、骨科、物理治疗和职业治疗的协调,应该用于早期发现和治疗,以确保最佳的患者结果。
{"title":"Peripartum Pubic Symphysis Diastasis.","authors":"Mary Katherine Anastasio,&nbsp;Albert T Anastasio,&nbsp;Jeffrey A Kuller","doi":"10.1097/OGX.0000000000001156","DOIUrl":"https://doi.org/10.1097/OGX.0000000000001156","url":null,"abstract":"<p><strong>Importance: </strong>Peripartum separation of the pubic symphysis is a rare but potentially severe complication of childbirth, which may lead to prolonged immobilization. Thus, prompt diagnosis and treatment are paramount.</p><p><strong>Objective: </strong>The purpose of this review is to define peripartum separation of the pubic symphysis and provide a thorough review of its etiology, clinical manifestations, diagnostic imaging techniques, management, and prognosis.</p><p><strong>Evidence acquisition: </strong>This was a literature review using PubMed and Google Scholar.</p><p><strong>Results: </strong>Peripartum pubic symphysis separation is defined as disruption of the pubic symphysis joint and ligamentous structures with greater than 1 cm of separation during delivery. Risk factors include fetal macrosomia, nulliparity, and precipitous labor. Patients often present with a sensation of something \"giving way\" in the pubic symphysis area at the time of delivery, or with severe pain in the pubic symphysis region with attempted mobilization postpartum. In severe cases, associated hematomas, pelvic fractures, sacroiliac joint disruption, and urinary tract injury may be seen. Imaging such as x-ray or ultrasound may be used to confirm the diagnosis. Although most patients recover well with conservative management, orthopedic surgical intervention may be indicated in more severe or unresolved cases.</p><p><strong>Conclusions and relevance: </strong>Pubic symphysis separation is increasingly identified peripartum due enhanced accessibility and utilization of imaging modalities. It can be debilitating and lead to prolonged immobility postpartum. Therefore, early recognition and diagnosis are important, as this can guide decision-making for management. A multidisciplinary team approach, including coordination with obstetrics, orthopedic surgery, physical therapy, and occupational therapy should be used for early detection and treatment to ensure optimal patient outcomes.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":null,"pages":null},"PeriodicalIF":6.2,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9708988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Cell-Free Fetal DNA for Genetic Evaluation in Copenhagen Pregnancy Loss Study (COPL): A Prospective Cohort Study 哥本哈根妊娠丢失研究(COPL)中无细胞胎儿DNA的遗传评价:一项前瞻性队列研究
4区 医学 Q2 Medicine Pub Date : 2023-06-01 DOI: 10.1097/ogx.0000000000001163
Tanja Schlaikjær Hartwig, Louise Ambye, Jennifer R. Gruhn, Jesper Friis Petersen, Tine Wrønding, Letizia Amato, Andrew Chi-Ho Chan, Boyang Ji, Maiken Hemme Bro-Jørgensen, Lene Werge, Mette Marie Babiel Schmidt Petersen, Clara Brinkmann, Julie Birch Petersen, Morten Dunø, Iben Bache, Markus J. Herrgård, Finn Stener Jørgensen, Eva R. Hoffmann, Henriette Svarre Nielsen
(Abstracted from Lancet 2023;401:762–771 Spontaneous pregnancy loss occurs in approximately 1 in 4 pregnancies; however, diagnostic workup is mostly restricted to women with recurrent pregnancy loss. The lack of workup on first pregnancy loss is likely a result of the high de novo fetal aneuploidy rate; however, this ignores the association of euploid pregnancy loss with an increased risk of future losses.
(摘自Lancet 2023; 401:762-771)自然流产发生率约为1 / 4;然而,诊断检查主要局限于复发性流产的妇女。缺乏对首次妊娠丢失的检查可能是由于新生儿非整倍体率高;然而,这忽略了整倍体妊娠丢失与未来丢失风险增加的关联。
{"title":"Cell-Free Fetal DNA for Genetic Evaluation in Copenhagen Pregnancy Loss Study (COPL): A Prospective Cohort Study","authors":"Tanja Schlaikjær Hartwig, Louise Ambye, Jennifer R. Gruhn, Jesper Friis Petersen, Tine Wrønding, Letizia Amato, Andrew Chi-Ho Chan, Boyang Ji, Maiken Hemme Bro-Jørgensen, Lene Werge, Mette Marie Babiel Schmidt Petersen, Clara Brinkmann, Julie Birch Petersen, Morten Dunø, Iben Bache, Markus J. Herrgård, Finn Stener Jørgensen, Eva R. Hoffmann, Henriette Svarre Nielsen","doi":"10.1097/ogx.0000000000001163","DOIUrl":"https://doi.org/10.1097/ogx.0000000000001163","url":null,"abstract":"(Abstracted from Lancet 2023;401:762–771 Spontaneous pregnancy loss occurs in approximately 1 in 4 pregnancies; however, diagnostic workup is mostly restricted to women with recurrent pregnancy loss. The lack of workup on first pregnancy loss is likely a result of the high de novo fetal aneuploidy rate; however, this ignores the association of euploid pregnancy loss with an increased risk of future losses.","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135946461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perioperative Opioid Dispensing and Persistent Use After Benign Hysterectomy: A Systematic Review and Meta-analysis 良性子宫切除术后围手术期阿片类药物分配和持续使用:系统回顾和荟萃分析
4区 医学 Q2 Medicine Pub Date : 2023-06-01 DOI: 10.1097/ogx.0000000000001164
Kamran Hessami, Jennifer Welch, Anja Frost, Abdelrahman AlAshqar, Sara E. Arian, Ethan Gough, Mostafa A. Borahay
(Abstracted from Am J Obstet Gynecol 2022; doi: 10.1016/j.ajog.2022.12.015 Between 1999 and 2019, the opioid epidemic claimed the lives of nearly 250,000 individuals in the United States. Many patients first opioid prescription is dispensed in a surgical setting, and hysterectomy is the second most common surgical procedure in women.
(中华妇产科杂志,2022;1999年至2019年期间,阿片类药物流行病夺去了美国近25万人的生命。许多患者的第一次阿片类药物处方是在手术环境中分配的,子宫切除术是女性第二大最常见的外科手术。
{"title":"Perioperative Opioid Dispensing and Persistent Use After Benign Hysterectomy: A Systematic Review and Meta-analysis","authors":"Kamran Hessami, Jennifer Welch, Anja Frost, Abdelrahman AlAshqar, Sara E. Arian, Ethan Gough, Mostafa A. Borahay","doi":"10.1097/ogx.0000000000001164","DOIUrl":"https://doi.org/10.1097/ogx.0000000000001164","url":null,"abstract":"(Abstracted from Am J Obstet Gynecol 2022; doi: 10.1016/j.ajog.2022.12.015 Between 1999 and 2019, the opioid epidemic claimed the lives of nearly 250,000 individuals in the United States. Many patients first opioid prescription is dispensed in a surgical setting, and hysterectomy is the second most common surgical procedure in women.","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135946459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Obstetrical & Gynecological Survey
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1